Skip to content
Abouassaly – Pancreatitis episode artwork

May 25, 2023 54 min

Abouassaly – Pancreatitis

from Maryland CC Project

Dr. Chadi Abouassaly, Assistant Program Director of General Surgery at Medstar Washington Hospital Center and Associate Medical Director of the Trauma and Burn ICU presents a lecture on Pancreatitis as part of the DC5 lecture series.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Abouassaly – Pancreatitis

0:00 54:54
of matches

Transcript Auto-generated, may contain errors

All right. Good afternoon, everyone. I just want to introduce Dr. Abusali, who has graciously agreed to give us a talk on pancreatitis today. I assume we will have some more people trickle in, Dr. Abusali, but don't want to penalize those who made it on time. Dr. Abusali is a Washington Hospital Center trauma surgeon and critical care doc, who is the APD for the General Surgery Residency Program over there, and is going to speak today about pancreatitis. All right. Thank you. And thanks for the invite. Let me see if I can share my screen.

So, okay, thanks again for inviting me. There's obviously a lot to cover about pancreatitis, so I'll try and kind of summarize the introduction of what it is, and we'll talk a little bit about a few issues with the ICU care and who to admit to the ICU, at least, and how to manage these patients. So the definition of acute pancreatitis is obviously an intestinal inflammation and edema of the pancreatic tissue. As we all know, there's two different forms of pancreatitis, acute and chronic. You know, the chronic one, you know, the most problems we're going to deal with in the ICU or anywhere is basically the chronic pain and, you know, inability to digest anything with pancreatic insufficiency. And so we won't talk much about it except for saying that it exists. And having chronic pancreatitis doesn't rule you out from having acute pancreatitis on top of that. It's a problem, obviously, of, you know, chronic inflammation, fibrosis of the organ and inability to secrete, you know, enzymes and to digest. And the biggest issue, again, we face with is pain control.

And so if you see somebody in the ICU, that's going to be the, you know, the problem with them mostly is the pain control. As far as acute pancreatitis, it's an inflammation in the amount of the pancreatic tissue, and then that leads to destruction. And we'll talk a little bit about the pathophysiology, but that's the basically, you know, biggest problem with it is the destruction of pancreatic tissue, release of the enzymes and the, you know, local and systemic effects of all this inflammation and destruction. The presentation is usually with abdominal pain. It's usually acute onset, severe, mostly epigastric, and then kind of radiates to the back most of the time. But then also you can have a right upper quarter, left upper quarter pain, depending on where the inflammation is. I won't go into a lot of kind of the details on clinical findings that are interesting, but I'm pretty sure you guys have heard of the presentation of hemorrhagic pancreatitis where the skin changes and necrotic fat nodules under the skin.

The abdominal pain is usually associated with nausea and vomiting. Most patients will present after a few days of experiencing that, so they're a little bit behind to begin with. And the diagnosis is usually by clinical findings based on the abdominal exam and the amylase and lipase. The difference between those two is basically when one of them starts speaking versus the other, the amylase speaks first. And then usually kind of starts going down by day two or three. And so if you get somebody who's presented after five days of symptoms, the amylase might be normal. However, the lipase lags the peak and then stays around for a longer period of time. The diagnosis is made by having a serum amylase and lipase that are three times higher than the normal.

And then again, we'll go over what kind of imaging and modalities, but usually a CT scan is not required to make the diagnosis, but we'll talk about why it's important in case of severe pancreatitis, what to do with that. The anatomy, I wanted to just kind of touch base on the anatomy because it's important for two aspects, I think. First of all is where the pancreas is located and what kind of structures it affects around it that will kind of determine what kind of complications the patient has. And then just because of the location of the pancreas, it also kind of will dictate how we manage these complications and how they will present.

So that being said, a couple of things I want to point out is, you know, usually it's not as clear showing up like this behind the, you know, this is the pancreas basically. And it does not show like that basically in an operative field or any regular person. It will be covered by the momentum down here. The stomach will be kind of wrapped around it. There's going to be a lot of fat up top. And then the lesser momentum is going to be here covering everything. It is a retroperitoneal structure. And so, you know, the pain, again, usually that's why they have, you know, back pain with it. And it's going to be mostly epigastric.

And then again, the complications from pancreatitis other than the organ itself are related to the structures around it. So the stomach, the colon, the blood vessels that supply the pancreas itself and every other organ around it. And then obviously the cystic duct, the common bile duct, and all empty within the duodenum. This is basically another picture that I just wanted to show with the stomach reflected up, showing the body of the pancreas. I want to just point out a couple of structures here. The splenic artery kind of runs along the border of the pancreas and sometimes behind it on the upper edge of it. Also, there's a lot of gastric arteries that are around it. And again, it's a very vascular structure. Also, a little bit comes to play also is the presence of the middle colic artery that runs right here off of the SMA.

And then basically the portal vein is behind us over here on this side, way behind the pancreas. And this again plays a role. It's important just because of the complication that comes with the inflammation. If there's any questions, by the way, for anything, just please stop me and let me know. You guys welcome to interrupt. This is basically, again, just kind of a basic physiology. I'm sure you guys know that, but we'll just mention it, that, you know, the pancreas is a exocrine endocrine organ. You know, it regulates, you know, blood sugars, obviously, but also for our purposes of acute pancreatitis, the SNR cells will produce prolytic enzymes or proenzymes, basically, that gets activated when they hit the duodenum and meet the mucosal wall of the duodenum.

If they get activated here, there's some defense mechanism that the pancreas deals with. And we'll talk a little bit about what happens when those get overwhelmed or dysregulated. Again, there's a lot of blood supply to the pancreas, which is good, but also could be bad with some complications that we'll talk about later. And again, just want to point out the proximity of all these structures around it. And again, keep that in mind when we talk about local complication of pancreatitis and then approach to managing pancreatitis surgically or endoscopically or with interventional radiology or face the complications from it.

Okay, so acute pancreatitis, it's been reported that it's the most common abdominal presentation to the hospital. About 15 to 25% will have a necrotizing component of the pancreatitis, meaning that because of the inflammation or various reasons, that part of the pancreas is not getting enough blood flow and it will literally die. 20% of moderately severe to severe pancreatitis will have some organ dysfunction. That doesn't mean that they will stay with organ dysfunction for their hospitalization, but 20% of them will present with some form of organ dysfunction. Overall, mortality in acute pancreatitis has been getting better. From the late 90s to the early 2010s, it's decreased quite significantly to now it's about 5% overall mortality for all incoming pancreatitis. That obviously increases a lot with necrotizing pancreatitis, which is going to reach up to 17%.

What is the cause of their severe illness? It's in general, again, local complications from the location of the pancreas around stomach, duodenum, colon, and then the other systemic problems that happen is because of the inflammation and distributive hypovolemic shock that they present in it. And all patients with pancreatitis will present with some kind of hypovolemia or hypovolemic shock. So again, what is the etiology of acute pancreatitis? It's important for us to know the different aspects of it because we will need to kind of at some point reverse the cause or at least manage the cause until we can have the definitive treatment. The most common reason for pancreatitis, at least in the U.S., is gallstones. It's up to 70% of patients with pancreatitis have some kind of gallbladder disease and stones. Basically, the smaller the stone, the more likely the patient is going to develop pancreatitis.

The reason for this basically is either stones, and so that includes blockage of a common channel, and then which kind of leads to, you know, the pancreatic secretions kind of backing up and getting activated in the pancreas and then overwhelming the system, or basically reflux vial into the pancreatic duct and causing a chemical reaction. The treatment for this is ERCP and eventually call a cystectomy. The next reason I want to talk about the next cause is obviously ERCP. So treatment of this, you know, as it puts the patient at risk for pancreatitis, it depends on the, you know, the ERCP causing pancreatitis depends on obviously the experience of the proceduralist, why they're doing the procedure and what procedure are they doing. Is it for diagnostic purposes? Then the likelihood of pancreatitis is in the low, you know, single digits. If it's a therapeutic ERCP, meaning that they're going to.

you know, put a stent through the pancreatic duct or anything like that, then that would increase the chances of pancreatitis to about 25%. In our institution here, and I think in our system, the rate of pancreatitis from ERCP is pretty low. And I think that's just because of the volume that we have for these patients and for the procedure list. When do we do ERCP on patients with gallstones? Usually, you know, if they're in the ICU and they have pancreatitis only, most doctors will probably be comfortable with waiting for them till their symptoms get better and then evaluate if they need a procedure.

If they have a pancreatitis with some kind of a cholangitis or they're in septic shock, then I think that kind of pushes us more to kind of get that intervention done so we can clear the ducts and kind of help alleviate the septic shock. The cholecystectomy is the ultimate kind of goal of the management because you take out the reason why they have stone and then that prevents it from recurring. What we quote for patients is that recurrent pancreatitis after gallstone pancreatitis is about 20% lifetime, which is pretty high. And so our recommendation usually is to take out the gallbladder when the pancreatitis has gotten better within the acute phase. And if they have any complication from pancreatitis like pseudocyst or ascites, then that kind of pushes us to wait a little bit longer.

just because of the risk of complications from surgery is high and the chances of us, you know, worsening their pancreatitis is high if they have complications from pancreatitis. The next most common cause in the U.S. for acute pancreatitis is alcohol use. Most of it is from chronic alcohol use. There's really no underlying mechanism that's understood why at a certain point what was not causing problem for the patient from their pancreas causes it all of a sudden after, you know, five, six years of drinking. Maybe it's hypersecretion of enzymes that is generated by the alcohol use, but nobody really knows.

Hypertriglycideremia, usually it's in the range of a thousand milligram per deciliter usually, and it's really pretty rare. Same thing with hypercalcemia. Meds, I wanted to point out because it's really rare and it's self-limiting as long as we stop the inciting agent, but there's a lot of meds that cause it. And it's an important thing to consider in the ICU if all of a sudden your patient has pancreatitis and you can't really pinpoint something that causes it like a stone from the gallbladder or anything like that. So just kind of keep that in mind. It's always reported that pancreatic injury causes pancreatitis.

uh you know it's kind of debatable if we look at pancreatic injury causing pancreatitis like the classical acute pancreatitis we see it's usually a disruption of the pancreatic duct uh that causes elevated uh um you know uh amylase and lipase obviously uh but but they don't act as sick as the systemic patients just from the pancreatitis it's usually other things that are injured at the same time with the shock and all that that causes their illness but you know if you have a trauma that has a pancreatic injury then probably they need to get investigated And then anatomical anomalies like pancreatic divism or any kind of cysts off of the pancreatic duct or at the ampoula causes some obstruction of some pancreatitis.

So what happens after the original inciting event, either alcohol use or blockage or reflux, the prolytic enzymes will get activated in the body of the pancreas. And usually the pancreas has some defense mechanism and self-regulatory mechanism that controls the activated enzymes and kind of manages them. But when there's a big amount of prolytic enzymes that are getting activated or if the pancreas is injured or ischemic for some reason, that overwhelms usually the defense mechanism. And then the release of the trypsinogen and activation of trypsin will kind of lead to destruction of cells that releases more and it's kind of a vicious circle that kind of causes autodigestin and more release of the active enzymes. On top of that, you have a vascular injury because of the edema and the inflammation that causes microthrombosis, that causes ischemia, that worsens the cellular damage. And then the capillary leak around the microvasculature causes more edema. And then you have this potential ischemia reperfusion injury of the organ that causes more and more damage and more inflammation, more swelling, and again, it's a vicious circle. At a systemic level,

This causes a release of pro-inflammatory cytokines that causes the ARDS, the renal failure on top of the shock, and causes basically leaky vessels everywhere in the body. There's been a lot of grading systems for deciding if this is acute severe or moderately severe and predicting outcomes. You know, ever since Ransom's criteria started, and now we use more fancy kind of grading system and scoring systems, it's important for us to, you know, kind of grade pancreatitis or assess if it's severe or not, just to kind of make a decision about what level of care the patient needs. Now, you know, is that, you know, if the patient's whatever Ransom criteria or whatever you want to use is low, but the patient has heart failure and other system, are we going to leave them in the floor?

Probably not, but it just helps us for basically trying to triage those patients where they go. It definitely helps if you're interested in doing research as far as pancreatitis because, you know, grading those injuries are probably very necessary to do an adequate research project or any intervention you do. And then you set expectations for the family and the patient. You know, if they come in with an Apache score that's horrible, then you know what to tell them. They have a lot of organ failure on top of the pancreatitis. You know what to kind of make them expect.

So, and then again, you're, you know, we don't talk much about it, but resource allocation, you know, who is going to take that, you know, ICU bed that when you have only one left in the hospital, you know, those are all decisions that we have to make, unfortunately, more and more now these days. And then, you know, as far as like grading, we'll talk about different forms of grading, but some of the grading will help you when deciding, you know, are you going to call IR, are you going to call GI, are you going to call surgery to come and evaluate the patient based on, you know, what kind of disease process they have. So the classification in general depends on the severity. Mild acute pancreatitis is basically a...

absence of any organ failure, and that there's no local or systemic complications of the patient. So just elevated lipase, abdominal pain, then that's usually a mild form of pancreatitis, and I think most of those will kind of, you know, admit to the floor, get some IV fluid pain controlling, and get them out, hopefully. The moderately severe acute pancreatitis basically is in patients who have a transient organ failure, which results within 48 hours, and a local or systemic complication that does not kind of, again, the organ failure kind of goes away after 48 hours. So, you know, those patients are going to need a little bit more attention. So IMC, and we'll talk about, you know, how most patients with acute pancreatitis will require. But those patients are going to be a little bit more tricky than any of the, you know, the mild or the severe because you need to monitor them and you don't want to take an ICU bed. So those are the ones that are going to be a challenge because you need to make sure they're getting better.

But again, they might not meet criteria for ICU admission. The severe acute pancreatitis basically are the patients with a persistent organ failure that might involve one or multiple organs. Again, it could be AKI, it could be respiratory failure, it could be cardiomyopathy, it could be altered mental status, all of those things. The revised Atlanta classification depend on imaging and the presence of necrotic tissue or not, presence of fluid collection or not around the pancreas. And so in most patients, that's not going to come in play because most of them are going to be mild. And you might not want to get a CT scan on those if they get better after a couple liters of fluids. But once you get to the point where you're wondering if they're going to get better and need ICU stay, I think that comes in play.

I just put up the ransom criteria here because every single test I've taken for medical school or residency or fellowship, they had it on there and had to memorize it. Even though now we don't think that it's usually very helpful because it actually does not predict severity and does not predict need for ICU stay. But, you know, just looking at the numbers themselves, you can say, you know, these patients are going to die or have a higher likelihood of dying or not. But you don't know how they're going to go once you get the ransom criteria, even at 48 hours. So it's not really very helpful to.

decide where you're going to put that patient once you see it, unless, you know, they don't get better, which you're going to do that anyway. So again, I'm not sure what the benefit of this, which brings us to all of the other, unfortunately, grading systems or scoring systems for acute pancreatitis, which suffer from the same problem. Basically, it tells you how sick the patient is, but it's not going to predict very well. you know, what's going to happen in the next 24 hours. The best ones to do that are the Apache 2 score, you know, SOPA score and SIRS score. But those are just generalized, you know, organ failure and ICU admission and illness. So it's not specific to the pancreatitis. The BICEP score, which is the bedside, basically assessment of the inpatient assessment of the acute pancreatitis. It relies on BUN, altered mental status, SIRS, age, and plural effusions. Again, it's a good marker of how sick the patient is, but it's not specific for pancreatitis.

And so does somebody who meet those criteria goes to the ICU? Sure. But, you know, we don't know how they're going to do the next 24, 48 hours. The harmless acute pancreatitis score is basically designed to say who has pancreatitis that's not really that very severe. So if they don't have peritonitis regarding an abdominal exam, that's good. If they have a normal hematocrit, that's good. And if they have a normal creatinine, that's good. You know, again, you know, is that going to, you know, are you going to ignore that patient who has like a lactate of two or four or five with these, you know, findings? Probably not. But again, it's just kind of a guide to kind of tell you how sick the patient is.

And the Baltazar score basically is a scoring system based on CT findings of necrosis full of collections and inflammation. So I mentioned all of these just to kind of say that the best scoring systems for acute pancreatitis are the best scoring systems for ICU. And again, it gives you good measuring if you're doing research, if you're publishing, or if you're an administrator looking at how good your outcomes are. But if somebody's an organ failure, you're going to get into the ICU no matter what the underlying theology is. And again, these scoring systems are not very specific to pancreatitis, the ones that are specific to pancreatitis.

don't give you an idea of like how sick the patient overall is because again there's no organ failure here except for maybe like altered mental status same thing here you have no idea what the organ failures or not are going So do we admit to the ICU or not? I think it depends on, you know, what your hospital allows. You know, I'm pretty sure everybody on this phone call is the same. We have patients, you know, intubated boarding in the ED. We're running pressers sometimes on the floor until we open a bed somewhere that the patient can come. Other hospitals will not do that. And so if you have, if you're like 60 and you have, you know, some simple acute pancreatitis, you might get committed to the ICU just for monitoring just because the floor can't handle it. Obviously, any organ failure is going to buy you an ICU stay, hopefully.

And again, the scoring system has not been shown to be 100% reliable in terms of predicting the need for ICU or for predicting the clinical deterioration from pancreatitis itself. So we'll talk a little bit about the management, and we're going to divide it into these subjects, IV fluid management, pain control, antibiotics, nutritional support, and management of complications and organ support. The organ support aspect is easy. If they have ARDS, respiratory failure, then they need to be intubated. Acute kidney injury needs to be supported. They need dialysis. They need dialysis. And cardiac complications basically are mostly from chronic disease on top of the inflammatory state, and they just need some kind of support and blood pressure support if they are in septic or vasodilatory shock or hyperbolemic shock.

So we'll start a little bit about fluid resuscitations. And I'll just throw it out there. Every single patient with pancreatitis comes in with hypopolemia, and they will need fluid resuscitation. And that's because they've been vomiting for a few days. They haven't been able to take NPO. And again, they don't show up usually right at the symptom starts. And then again, because of the inflammation around the pancreas, there's a lot of sequestration in their retroperitoneum. And whatever fluid they give them, a bunch of it is going to go to that organ and to other areas. And then you need to make sure that you resuscitate them or resuscitate their intravascular volume.

When we do that, we reverse the pancreatic hyperperfusion. You obviously improve blood flow to and oxygen delivery to other organs. So you blunt or delay the effect of mortal system organ failure. There's been a few studies that looked at how much volume to give and what are the markers for us to kind of base our volume resuscitation on. So I'll just come out and say that, you know, there's some reasonable study that's looked at these two, you know, hemoglobin and BUN. And if you don't have a decrease in those, then...

sorry, then within 24 hours, then the outcome is worse. Either, you know, the hemoconcentration study looked at pancreatic necrosis. And if you don't, you know, improve their hemoconcentration within 24 hours, those patients will develop more pancreatic necrosis. And for the BUN, it looked at mortality. Again, does that help us, you know, knowing how much volume to give and what to give? And, you know, are those patients sick to begin with? No, but those are kind of things to look for in the first 24 hours. Those are the patients that are going to do worse.

brings us to the next question, which, you know, how much volume to give, how fast, and what to use. There was one study recently that looked at, they had patients basically that got the aggressive volume resuscitation versus normal volume resuscitation, and their aggressive volume resuscitation was giving a 20 cc per kg bolus and followed by 3 cc per kilogram per hour IV fluids for the first 48 hours. They didn't just leave them on, they kind of did a reassessment at like 2, 4, 12 hours, continuously through 48 hours, and then adjusted the fluid based on what they need, mostly down. But in those patients that got this big volume resuscitation to begin with, they noticed that what they described as fluid overload was more common in these patients. And these patients did not get better outcomes than the ones that had the lower resuscitation volumes, which were like 10 cc per kg and 1 to 1.5 cc per kg per op. Their fluid overload parameters were pulmonary edema, respiratory failure, and edema on exam. So a little bit vague, but again, they noticed that if we overshoot with the volume resuscitation, then...

then, you know, that doesn't really help the outcome, but kind of causes problem down the road. And so most of the recommendations now are to start with moderate hydration, you know, usually 10 cc per kg bolus to begin with, and then start some kind of fluid at 1.5 cc per kg per hour, and then follow these markers that we used about, you know, BUN, hematocrit, in addition to whatever you have in your hospital or whatever you feel comfortable to assess intravascular volume. That is obviously an echo, you know, if you believe in flow track, flow track, if, you know, if you have... you throw PA catheters into everybody, which I hope you don't, and use that, but just some kind of a marker intravascular volume, and basically check urine output, lab lactate clearance, and all that stuff. Obviously, urine output becomes tricky if the patient comes in with an AKI. Some of them will get better. Some of them won't get better right away. And then the question is, urine output reflection of intravascular volume, or is it the kidney that's damaged that's not making it in urine? And again, we're not going to go into how to assess intravascular volume here, because that's another one year of lectures and teaching, but that's the principle with this.

So what do we use? LR versus normal saline. You know, there's some studies, again, that now more likely that in any fluid resuscitation, we prefer LR versus normal saline because of... Various factors, there has been some weak studies looking at acute pancreatitis only, but I think, again, I would use your common sense based on your electrolyte abnormality. If they're hypoinatremic, use normal saline. If they have hypercalcemia, basically, don't use LR, maybe because it has a bigger calcium count in it. But in general, albumin, like anything else, has not been proven to be any better unless they have some kind of liver failure and then obviously no head of starch or anything like that. So again, the choice of fluid resuscitation.

just applies to any kind of resuscitation patient in the ICU. And then again, the goal is to resuscitate those patients quickly and within 48 hours. And then once you hit that 48-hour mark, then kind of reassess, you know, your goals of, you know, IV fluid. If you're still volume, if you still like your markers of, you know, urine output are not well, then probably time to cut back on the IV fluid just because, you know, it's probably not going to do anything at that point and you might have some problem down the road with it. Pitfalls for fluid resuscitations are...

presence of CHF and end-stage renal disease. And I say that because, not because we overdo it with those patients, but because we under-resuscitate those patients all the time. At least as soon as they get to the ICU, we notice that they've been in the hospital for a couple of days. And we've been kind of very ginger with our IV fluid because we're worried, you know, obviously for their unit, they don't make any urine and they were worried about the respiratory status and cardiac stress and all the stretching and all that. But those are most commonly the patients that come in under-resuscitated to the ICU. And again, that kind of prompts that, you know, the...

more vigorous resuscitation maybe, but also more kind of watching them and getting better monitoring on them of some sort. And then, you know, abdominal compartment syndrome is another pitfall of over-resuscitating them. We have, you know, as a surgeon, I have not seen abdominal compartment syndrome in a while. At least we see it, but it's not as common as before. And again, that's because we're more judicious with our IV-4 resuscitation, but it is, acute pancreatitis is one of the risk factors for developing abdominal compartment syndrome.

Pain control, again, all patients will present with abdominal pain to the hospital with acute pancreatitis. Giving them IV fluids and fixing their shock is going to help with their pain. Sorry. Reversing the ischemia is going to help with the pain management. But at some point, they will need some kind of narcotics or some kind of meds for pain control. When I was in residency, I was thought never to give morphine to anybody with cholangitis or any obstructive biliary disease or pancreatitis because of the risk of sphincter or OD, increasing pressure.

and they're causing worsening symptoms, but that has not been clinically proven and no really clinical significance have been shown with morphine. So whatever works for the patient, you know, give it, manage their pain because they're not going to get better if they're in a lot of pain. You know, obviously, you know, try and use multimodal pain therapy, but at some point they will need some kind of narcotics, most of them. Nutritional support, like anybody in the ICU, is extremely very important and nobody's going to get any better without any nutritional support. What do we pick? You know, internal nutrition is obviously the best option to begin with and should be attempted in any patient. When to start it? We've kind of agreed that, you know, starting immediate internal nutrition on everybody that comes to the ICU might not have a lot of benefit to it, but we don't want to delay too much.

And I say that because if you're going to drop an NG tube in somebody and start feeding them as soon as they get to the ICU because they have an AKI and they have an altered mental status, just putting that NG tube has some risk to it. And maybe if we wait 24 hours and resuscitate them and their mental status get better, then we can avoid putting an NG tube and they can eat. That's the only purpose to do that. Feeding the patient with pancreatitis has not been shown to make pancreatitis worse. The thought again before was that it will...

activate enzyme secretions that will make the pancreatitis worse, but that has not borne out with a lot of studies done. The most common complications with enteric nutrition, either oral or through NG tube, is basically the inflammation of the retroperitoneal organ, the organ that is sitting around the stomach and the duodenum and the colon, causes an ileus versus a pseudo obstruction and patients can't tolerate their two feeds and they have worse pain and they start vomiting. So that's usually the limiting factor for enteric nutrition. So again, it's probably okay to wait 24 hours, resuscitate the patient, see how they're doing, and then start nutrition on them. If they're on like 20 of norepi and vaso and diputamine and something else, then maybe we can wait a little bit longer just because of, again, it's not been proven, but stress on the GI tract with nutrition and high pressure requirements is a little bit iffy in most places.

So the next question is, should we start everybody on parenteral nutrition? Obviously, everybody knows by now, the answer is no. Internal nutrition alone improves outcomes in most patients that can tolerate it. There have been some studies that looked at supplementing internal nutrition with parenteral nutrition, either early or late. Both of those kind of options don't do any good and then kind of worsens the outcomes basically because of complications. Internal nutrition is good because it maintains the intestinal barrier, prevents translocation of bacteria.

It helps actually with the alias resolution and return of GI function. And again, everything has complications to it. Having an NG tube or putting a Dobhoff has some complications in it, but usually they're less severe than the complications from parental nutrition with line infections and other complications. Early versus late, again, like I said, probably we don't need to just drop an NG tube in everybody or a Dobhoff and start nutrition on them as soon as they hit the ICU. The earlier they're better, but I think you have 24, 48 hours, up to 72 hours to kind of resuscitate them.

and start, you know, tube feeds. What route to pick? Oral is great if they're not intubated and they can maintain their airway and they can tolerate it. And G-tube is the next best option. And then if they cannot tolerate, then G-tube feeds because, again, of the local inflammation and some gastroparesis because of the pancreatitis, then a post-pyloric tube would probably be reasonable too. And again, you can keep trying these things for the first 72 hours. If patients can't tolerate the first day, then start it again. And then up to 72 hours, it's probably reasonable to keep attempting. What kind of formulas to use?

I don't think, you know, the common sense would say you use something with low fat and semi-elemental for digestion. But, you know, it depends on what you have in the hospital. And some nitricoloric intake and protein intake is probably better than nothing. So, you know, what are the things that are going to make you stop nutrition in these patients? High residuals that they can tolerate it, increased pain when you start tube feeds, or severe distension. And again, those are all signs of some kind of an alias that hasn't resolved or some kind of a pseudo obstruction. And we need to kind of step back and think about parenteral nutrition. And the other thing that we have to think about is that if you give them some kind of nutritional support and they start having a lot of diarrhea, then we kind of need to reassess and think about changing the formula just to kind of make sure that we're not causing the diarrhea.

The parental route, again, it's less preferred, less resort. It does increase mortality, but not clear if it's because the patient is sick to begin with or because of their problems with their TPN. And again, like I said before, there's no role for supplemental parental nutrition if they are tolerating their entire route nutrition. Any questions about nutrition or anything that I've said before? Okay, we'll move on to antibiotics. You know, no matter how sick the patients come in with pancreatitis, there's no role for prophylactic antibiotic and acute pancreatitis just for the pancreatitis. Think about that. 20% of them will develop some kind of infection outside of the pancreas. And that includes pneumonia, that includes bloodstream infections, other kinds of infections. And they will stay in their ICU for a long, long time if they come to the ICU and the hospital. And so you want to save those antibiotics for when you really need them. And somebody with acute pancreatitis who is sick, unless you have evidence of...

pancreatic infection on CT or infected pancreatic necrosis, then the teaching is not to give them any antibiotics at all. It is most of the time a chemical inflammation reaction that leads to all the problem and not an infection. management of the complications and organ failure. Again, like I said before, the reason why I showed the anatomy at the beginning is that the local complications are mostly due to where the pancreas is and the surrounding structures. And so we'll talk about those a little bit more in detail. The systemic effects of pancreatitis are due to the pro-inflammatory cytokines are released and the shock basically that they come in with or that gets persisted because of how severe their pancreatitis is or because they have something dead or something like that.

Those are AKIs requiring CRT sometimes, ARDS requiring intubation, cardiac insufficiency, altered mental state. Obviously, the management of those depends on what's causing them and depends on your routine and how you do it. It's nothing specific to the pancreatitis, but those will happen quite frequently in severe pancreatitis. The local complications we'll talk about are, again, based on the anatomy we showed yesterday, the pancreas has a lot of blood supply to it. The spleenic artery runs right behind the pancreas or right on top of the pancreas. And, you know, the enzymes there will eat that vessel and causes the pseudoaneurysms. Gastric arteries are around there too. Epipholic arteries are around there too. And so those all have their risk of basically developing pseudoaneurysm and developing into hemorrhagic pancreatitis or some massive bleed from the pancreatitis. Those are patients that if you can resuscitate and get to IR, they will do a lot better than, you know, us taking into the OR and trying to, you know, dissect in a bath of like dead tissue and trying to find an artery to clip.

they will do really well with IR embolization. Pancreatic, and one more complication that I want to talk about in patients who are a blood vessel is basically the metal colic artery that supplies the transverse colon is very intimately involved with the pancreas and just kind of runs under it and goes there. So with severe inflammation of the pancreas, sometimes that artery kind of gets obstructed and causes ischemia of the colon. It doesn't happen frequently, but it is a known complication of the pancreatitis. And in those patients that...

you know, you're doing all the right thing, you're resuscitating them, you have them, you know, you have their, you know, infected pancreatic necrosis drained and you have inappropriate antibiotics and they're still getting sick and getting sicker. That's something, you know, those are the patients we'll talk about in a little bit that might require an exploration just to kind of see, make sure there's nothing dead. And sometimes it's the transverse colon that's dead and those patients don't do great. But, you know, if you take out that tissue, then maybe they'll have a chance of recovering. Pancreatic fluid collections happen a lot in pancreatitis. Most of them will resolve spontaneously. If they don't, then they form pseudocysts. Both these entities do not need kind of emergency, you know, intervention unless you're suspecting some infection. And most of them will cause, you know, at least the pseudocysts will cause some local, you know, effects on the stomach or the duodenum or the colon based on where it is. And those can be managed endoscopically at some time once the patient recovers from everything. Again, the only time you would intervene on those in the ICU if there's a suspicion of...

of infection in that fluid. So brings me to pancreatic debridement, which basically has changed a lot since I was a resident. You know, if a patient is sick, we used to take him to the OR and kind of try to save them by debridging the tissue. If anybody's been involved in that, that is the most miserable operation on the surgeon. And on the patient, too, you can't tell what's dead, what's inflamed. You don't know what you're kind of picking at. It's really an awful operation. And, you know, you have you have, you know, depending on where the inflammation necrosis is, you have a splenic artery and splenic vein and you have, you know, the mesoteric vessels hanging around there. And it's just kind of a miserable operation. So now what we do is we delay intervention as much as we can just to allow the necrosis and the death to kind of demarcate and become very obvious when we go into the OR.

And that includes in necrotizing pancreatitis. When we do that, I mean, we wait not a couple of weeks or three weeks, but like a month or so in order to go in and kind of debride the tissue. Then you're just going in and scooping out that stuff. It's less bleeding. They don't have as many fistulas forming. And you're just basically kind of giving them the best chance. What that means is that the patient is going to be sick when they have the pancreatic necrosis and they're going to be sick for a while.

So we just have to be patient. We have to support them. We have to improve the nutritional situation and then eventually go to the operating room in order to kind of clean up and, you know, take out that pro-inflammatory kind of, you know, collection of dead tissue. So again, in the past, we used to do an anterior approach, which you go in, you kind of try to lift the stomach up and then you go through the omentum and then go through and go to behind the stomach. And usually because of the inflammation, it's kind of very miserable and everything's stuck and all that stuff. Now, what we do is basically do this step of approach, which I'm going to show you what that means. So this is across, you know, section of the body. This is supposed to indicate the pancreatic necrosis. This is an IR drain that's put in.

And that's draining all this stuff. This can get upsized by IR up to the point where this tract is matured over here, meaning that once you take this out, it's not going to collapse. And once that happens, we can take out this drain and then follow this drain in. basically, to the necrotic tissue and then kind of debride it that way. This avoids us going through the belly. Technically, the peritoneum is still, you know, a clean area that, you know, because of the necrosis is contained to the retroperitoneum. So we don't have to go through here and, you know, kind of contaminate the peritoneum. And all you're doing basically is cleaning up the retroperitoneum from the necrotic tissue. This only kind of is done realistically if the necrosis is very well organized, obviously.

And that's called the step-up approach. And there was a study, the PANTER study, basically, that kind of showed better mortality and hospital stay and lower complication. And that's kind of the approach that we try to use every single time. So when do we do early surgical intervention? Like I said, if there's any suspicion of any ischemic bowel, and again, the colon is a high culprit, if there's any perforation because of IR or because of whatever reason, or if there's a complication from the IR procedure or no improvement after IR intervention.

So if they drain that, you know, fluid or that kind of necrosis and the patient is still kind of dying, then it's probably a good conversation to have with the family if we want to pursue an OR. Because most of those patients will not do well. And an open neck resectomy will, you know, they have multiple operation, acreatic fistulas and prolonged drainage. The other reason I want to talk about is also abdominal compartment syndrome, you know, with resuscitation. Those will present relatively early and those will need decompression, basically. And the goal of the decompression is to kind of relieve the compartment syndrome, but not do anything with the retroperitoneum. So we usually just open the abdomen, let it be, and then unless, again, there's any evidence of.

anything dead. So, you know, what do we do? Overall, kind of like a last minute of the talk, then we open to questions. The diagnosis is, again, based on abdominal pain and, you know, elevated lipase, three times higher than usual. And then once you get the diagnosis, then we need to kind of decide how severe the pancreatitis is. And that depends on organ failures. That depends on their vitals, you know, heart rate, respiratory rate, O2 set, blood pressure, and then their labs. You know, they have elevated lactate, BUN is high, hemoglobin, creatinine.

And then that kind of makes you decide if you want to admit it to the ICU based on those labs and based on any organ dysfunction. All of those patients, again, will need IV fluid resuscitation. And, you know, you have to do it based on what you're comfortable with and how you resuscitate all other patients based on, you know, assessing the intravascular volume. And then they need continued repeated reassessment of their vitals, of their labs. Again, we talked about, you know, BUM and hemoglobin saying hi after 24 hours, those patients will do worse.

And then, you know, where are you going to put them? Are you going to put them in the ICU? Are you going to put them in the IMC or on the floor? Again, that depends on your hospital and that depends on how sick the patient is and how much attention they need from you and from the nurses and from the other staff. There's no need to get a CT scan on everybody unless, you know, they're admitted to the ICU. I think then they have severe pancreatitis and you need to kind of get an idea. The recommendation basically is to try and wait unless you're looking for something specific within the first 24 hours, because by 72 hours, you're going to pick up if there's any pancreatic necrosis or there's anything funky that you need to address at that point. No antibiotics, just for pancreatitis.

Remember, nutrition, you don't have to kind of start it right away. And then another thing is that, you know, once you hit the mark of 48 hours, you just kind of rethink of your resuscitation strategy because at that point, if their kidney is still failing, it's not clear that more volume is going to, you know, help. So reassess, you know, how much volume they have and how much they can. Tolerate still. Be patient, you know, if they're sick, but they're not getting sicker, then you just need to support them. Again, the caveats is that you've got to make sure that there's nothing dead in their abdomen, that they don't have abdominal department syndrome.

And they don't have anything else that you're missing as far as their septic or visibilatory shock. And again, always ask for help. I got our surgery, ID. Those are complicated patients with complicated problems. And I think that's it. Thank you. Dr. Abbas, I thank you so much. Sure. See if anybody has any questions. Let's check in the chat as well.

Beyond Hope Project with Jason Tharp Beyond Hope Project Welcome to 'Beyond Hope Project,' a beacon of inspiration in the podcast world. Join Jason Tharp as we embark on a transformative journey, exploring stories that awaken the will to start anew and find the strength to rise from setbacks. 'Beyond Hope Project' is about lighting the way to your starting line, not dictating your path. We delve into narratives that foster optimism and belief in a future where dreams become achievements. Each episode is a tapestry of positivity, enthusiasm, and comforting support, resonating with the essence of hope. This podcast goes beyond storytelling; it's a movement of positive change rooted in authenticity and transparency. We provide real tools for real journeys, infusing more hope and joy into the world. 'Beyond Hope Project' stands as a testament to the transformative power of hope and the limitless potential of the human spirit. Join us in transcending boundaries and breaking barriers. Here, we prove dai Veteran Chat Project Kyle Turner Our goal is to reach as many Veterans as we can. We noticed a lot of the podcast personalities tend to be unrelatable to the every day joe. Not taking anything away from anyone just hoping to give more people a place to feel connected to something. KZ and Kyle are Army vets who deployed together for OIF 07-09 and OND. Now close to 15 years later we are finding a way to open up about our issues, and find a way to build a community. Paramedic Philanthropy Project Melissa Ade Podcast by Melissa Ade Bigfoot Information Project Podcast Bigfoot Information Project Occasional conversations with leading researchers and investigators regarding the animal commonly referred to as bigfoot.

Frequently asked questions

How long is this episode of Maryland CC Project?

This episode is 54 minutes long.

When was this Maryland CC Project episode published?

This episode was published on May 25, 2023.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Maryland CC Project episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.